Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007569
Abstract: Key Points • Patients who underwent core needle biopsy are more likely to have poor-risk disease features and inadequate tissue for molecular analyses.• Increasing tissue requirements of biomarker-driven trials may exclude patients with high-risk DLBCL… read more here.
Keywords: increasing tissue; trials may; risk; risk disease ... See more keywords